,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1457618,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7162,TPBG,https://ctdbase.org/detail.go?type=gene&acc=7162,,,7162,TPBG,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TPBG mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1,1457619,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164,TPD52L1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TPD52L1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
2,1457620,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,89882,TPD52L3,https://ctdbase.org/detail.go?type=gene&acc=89882,,,89882,TPD52L3,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TPD52L3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
3,1458240,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276,TTR,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid affects the reaction [thyroxine binds to TTR protein],,,PMID:27528273,https://www.ncbi.nlm.nih.gov/pubmed/27528273,27528273,,
4,1458241,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280,TUBB2A,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TUBB2A mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
5,1458242,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10383,TUBB4B,https://ctdbase.org/detail.go?type=gene&acc=10383,,,10383,TUBB4B,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TUBB4B mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
6,1458243,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,51175,TUBE1,https://ctdbase.org/detail.go?type=gene&acc=51175,,,51175,TUBE1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TUBE1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
7,1458244,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,562692,TUFT1A,https://ctdbase.org/detail.go?type=gene&acc=562692,,,562692,tuft1a,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TUFT1A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
8,1458245,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,55787,TXLNG,https://ctdbase.org/detail.go?type=gene&acc=55787,,,55787,TXLNG,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TXLNG mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
9,1458246,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57544,TXNDC16,https://ctdbase.org/detail.go?type=gene&acc=57544,,,57544,TXNDC16,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TXNDC16 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
10,1458247,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628,TXNIP,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TXNIP mRNA,,,PMID:23567314|PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/23567314|https://www.ncbi.nlm.nih.gov/pubmed/32588087,23567314|32588087,,
11,1458248,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7297,TYK2,https://ctdbase.org/detail.go?type=gene&acc=7297,,,7297,TYK2,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TYK2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
12,1459961,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498,XDH,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of XDH mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
13,1459962,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,389610,XKR5,https://ctdbase.org/detail.go?type=gene&acc=389610,,,389610,XKR5,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of XKR5 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
14,1459963,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,402415,XKRX,https://ctdbase.org/detail.go?type=gene&acc=402415,,,402415,XKRX,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of XKRX mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
15,1459964,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7512,XPNPEP2,https://ctdbase.org/detail.go?type=gene&acc=7512,,,7512,XPNPEP2,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of XPNPEP2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
16,1459965,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57510,XPO5,https://ctdbase.org/detail.go?type=gene&acc=57510,,,57510,XPO5,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of XPO5 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
17,1459966,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,11260,XPOT,https://ctdbase.org/detail.go?type=gene&acc=11260,,,11260,XPOT,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of XPOT mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
18,1459967,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57002,YAE1,https://ctdbase.org/detail.go?type=gene&acc=57002,,,57002,YAE1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of YAE1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
19,1459968,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,8565,YARS1,https://ctdbase.org/detail.go?type=gene&acc=8565,,,8565,YARS1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of YARS1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
20,1460421,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,9839,ZEB2,https://ctdbase.org/detail.go?type=gene&acc=9839,,,9839,ZEB2,10090,Mus musculus (house mouse),PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of ZEB2 mrna],,,PMID:32534105,https://www.ncbi.nlm.nih.gov/pubmed/32534105,32534105,,
21,1460422,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637,ZFAND2A,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of ZFAND2A mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
22,1460423,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57623,ZFAT,https://ctdbase.org/detail.go?type=gene&acc=57623,,,57623,ZFAT,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of ZFAT mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
23,1460424,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,57732,ZFYVE28,https://ctdbase.org/detail.go?type=gene&acc=57732,,,57732,ZFYVE28,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZFYVE28 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
24,1460425,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84619,ZGPAT,https://ctdbase.org/detail.go?type=gene&acc=84619,,,84619,ZGPAT,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZGPAT mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
25,1460426,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,55345,ZGRF1,https://ctdbase.org/detail.go?type=gene&acc=55345,,,55345,ZGRF1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZGRF1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
26,1460427,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,23660,ZKSCAN5,https://ctdbase.org/detail.go?type=gene&acc=23660,,,23660,ZKSCAN5,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZKSCAN5 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
27,1460428,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,84460,ZMAT1,https://ctdbase.org/detail.go?type=gene&acc=84460,,,84460,ZMAT1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of ZMAT1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
28,1457281,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,84343,HPS3,https://ctdbase.org/detail.go?type=gene&acc=84343,,,84343,HPS3,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of HPS3 mrna|flusilazole results in increased expression of HPS3 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
29,1457282,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,79803,HPS6,https://ctdbase.org/detail.go?type=gene&acc=79803,,,79803,HPS6,10090,Mus musculus (house mouse),Flusilazole affects the expression of HPS6 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
30,1457283,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,90161,HS6ST2,https://ctdbase.org/detail.go?type=gene&acc=90161,,,90161,HS6ST2,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of HS6ST2 mrna|flusilazole results in increased expression of HS6ST2 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
31,1457284,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,565155,HSP90AA1.2,https://ctdbase.org/detail.go?type=gene&acc=565155,,,565155,hsp90aa1.2,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of HSP90AA1.2 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
32,1457285,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,565082,HTRA1B,https://ctdbase.org/detail.go?type=gene&acc=565082,,,565082,htra1b,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of HTRA1B mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
33,1457286,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,336655,ICN,https://ctdbase.org/detail.go?type=gene&acc=336655,,,336655,icn,7955,Danio rerio (zebrafish),Flusilazole affects the expression of ICN mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
34,1457287,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3398,ID2,https://ctdbase.org/detail.go?type=gene&acc=3398,,,3398,ID2,10090,Mus musculus (house mouse),Flusilazole affects the expression of ID2 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
35,1457610,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,23210,JMJD6,https://ctdbase.org/detail.go?type=gene&acc=23210,,,23210,JMJD6,10090,Mus musculus (house mouse),Flusilazole affects the expression of JMJD6 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
36,1457611,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,553179,KITLGA,https://ctdbase.org/detail.go?type=gene&acc=553179,,,553179,kitlga,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of KITLGA mrna|flusilazole results in decreased expression of KITLGA mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
37,1457612,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,117508,KLF2A,https://ctdbase.org/detail.go?type=gene&acc=117508,,,117508,klf2a,7955,Danio rerio (zebrafish),Flusilazole affects the expression of KLF2A mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
38,1457613,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,23276,KLHL18,https://ctdbase.org/detail.go?type=gene&acc=23276,,,23276,KLHL18,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of KLHL18 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
39,1457614,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3916,LAMP1,https://ctdbase.org/detail.go?type=gene&acc=3916,,,3916,LAMP1,10116,Rattus norvegicus (Norway rat),Flusilazole results in decreased expression of LAMP1 mRNA,,,PMID:33032228,https://www.ncbi.nlm.nih.gov/pubmed/33032228,33032228,,
40,1457615,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3936,LCP1,https://ctdbase.org/detail.go?type=gene&acc=3936,,,3936,LCP1,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of LCP1 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
41,1457616,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949,LDLR,10090,Mus musculus (house mouse),Flusilazole affects the expression of LDLR mRNA,,,PMID:21195148|PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/21195148|https://www.ncbi.nlm.nih.gov/pubmed/22634333,21195148|22634333,,
42,1457617,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176,LEF1,10090,Mus musculus (house mouse),Flusilazole affects the expression of LEF1 mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
43,1457779,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,4047,LSS,https://ctdbase.org/detail.go?type=gene&acc=4047,,,4047,LSS,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of LSS mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
44,1458472,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23011,RAB21,https://ctdbase.org/detail.go?type=gene&acc=23011,,,23011,RAB21,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB21 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
45,1458473,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51715,RAB23,https://ctdbase.org/detail.go?type=gene&acc=51715,,,51715,RAB23,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB23 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
46,1458474,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5862,RAB2A,https://ctdbase.org/detail.go?type=gene&acc=5862,,,5862,RAB2A,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB2A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
47,1458475,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10981,RAB32,https://ctdbase.org/detail.go?type=gene&acc=10981,,,10981,RAB32,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB32 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
48,1458476,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11021,RAB35,https://ctdbase.org/detail.go?type=gene&acc=11021,,,11021,RAB35,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB35 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
49,1458477,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22930,RAB3GAP1,https://ctdbase.org/detail.go?type=gene&acc=22930,,,22930,RAB3GAP1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB3GAP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
50,1458478,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,25782,RAB3GAP2,https://ctdbase.org/detail.go?type=gene&acc=25782,,,25782,RAB3GAP2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB3GAP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
51,1457940,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,106648,CYP4F15,https://ctdbase.org/detail.go?type=gene&acc=106648,,,106648,Cyp4f15,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYP4F15 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYP4F15 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CYP4F15 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
52,1457941,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,106648,CYP4F15,https://ctdbase.org/detail.go?type=gene&acc=106648,,,106648,Cyp4f15,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of CYP4F15 mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
53,1457942,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,70101,CYP4F16,https://ctdbase.org/detail.go?type=gene&acc=70101,,,70101,Cyp4f16,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYP4F16 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
54,1457943,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8529,CYP4F2,https://ctdbase.org/detail.go?type=gene&acc=8529,,,8529,CYP4F2,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CYP4F2 mRNA,,,PMID:36864359,https://www.ncbi.nlm.nih.gov/pubmed/36864359,36864359,,
55,1457944,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,266689,CYP4F6,https://ctdbase.org/detail.go?type=gene&acc=266689,,,266689,Cyp4f6,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of CYP4F6 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
56,1458107,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2185,PTK2B,https://ctdbase.org/detail.go?type=gene&acc=2185,,,2185,PTK2B,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PTK2B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
57,1458108,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,245950,PTK2BB,https://ctdbase.org/detail.go?type=gene&acc=245950,,,245950,ptk2bb,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTK2BB mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
58,1458109,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5754,PTK7,https://ctdbase.org/detail.go?type=gene&acc=5754,,,5754,PTK7,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PTK7 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
59,1458376,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5784,PTPN14,https://ctdbase.org/detail.go?type=gene&acc=5784,,,5784,PTPN14,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PTPN14 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
60,1458377,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,11099,PTPN21,https://ctdbase.org/detail.go?type=gene&acc=11099,,,11099,PTPN21,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTPN21 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
61,1458378,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26191,PTPN22,https://ctdbase.org/detail.go?type=gene&acc=26191,,,26191,PTPN22,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PTPN22 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
62,1458379,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100007322,PTPN23A,https://ctdbase.org/detail.go?type=gene&acc=100007322,,,100007322,ptpn23a,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTPN23A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
63,1458380,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5774,PTPN3,https://ctdbase.org/detail.go?type=gene&acc=5774,,,5774,PTPN3,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTPN3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
64,1458381,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5777,PTPN6,https://ctdbase.org/detail.go?type=gene&acc=5777,,,5777,PTPN6,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PTPN6 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
65,1458382,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5787,PTPRB,https://ctdbase.org/detail.go?type=gene&acc=5787,,,5787,PTPRB,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PTPRB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
66,1458383,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5788,PTPRC,https://ctdbase.org/detail.go?type=gene&acc=5788,,,5788,PTPRC,9913,Bos taurus (cattle),Perfluorooctane sulfonic acid results in decreased methylation of PTPRC intron|perfluorooctane sulfonic acid results in decreased expression of PTPRC mRNA,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
67,1458479,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84418,CYSTM1,https://ctdbase.org/detail.go?type=gene&acc=84418,,,84418,CYSTM1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYSTM1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYSTM1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
68,1458480,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9267,CYTH1,https://ctdbase.org/detail.go?type=gene&acc=9267,,,9267,CYTH1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CYTH1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
69,1458481,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,321938,CYTH1A,https://ctdbase.org/detail.go?type=gene&acc=321938,,,321938,cyth1a,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of CYTH1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
70,1458482,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,728294,D2HGDH,https://ctdbase.org/detail.go?type=gene&acc=728294,,,728294,D2HGDH,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of D2HGDH mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
71,1459511,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23576,DDAH1,https://ctdbase.org/detail.go?type=gene&acc=23576,,,23576,DDAH1,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of DDAH1 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
72,1459512,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644,DDC,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of DDC mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
73,1459513,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821,DDHD1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of DDHD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
74,1460258,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55647,RAB20,https://ctdbase.org/detail.go?type=gene&acc=55647,,,55647,RAB20,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RAB20 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
75,1460259,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23011,RAB21,https://ctdbase.org/detail.go?type=gene&acc=23011,,,23011,RAB21,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of RAB21 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
76,1460260,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51715,RAB23,https://ctdbase.org/detail.go?type=gene&acc=51715,,,51715,RAB23,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RAB23 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
77,1460924,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,338382,RAB7B,https://ctdbase.org/detail.go?type=gene&acc=338382,,,338382,RAB7B,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RAB7B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
78,1460925,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4218,RAB8A,https://ctdbase.org/detail.go?type=gene&acc=4218,,,4218,RAB8A,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of RAB8A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
79,1460926,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56382,RAB9,https://ctdbase.org/detail.go?type=gene&acc=56382,,,56382,Rab9,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RAB9 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RAB9 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
80,1460927,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56382,RAB9,https://ctdbase.org/detail.go?type=gene&acc=56382,,,56382,Rab9,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of RAB9 mrna|ppara protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of RAB9 mrna],,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
81,1460754,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6748,SSR4,https://ctdbase.org/detail.go?type=gene&acc=6748,,,6748,SSR4,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SSR4 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
82,1457945,107649,Toxin and Toxin Target Database (T3DB),Beryllium(2+),T3D0042,Beryllium,http://www.t3db.ca/toxins/T3D0042,BE0005070,"HLA class II histocompatibility antigen, DP alpha 1 chain",http://www.t3db.ca/biodb/bio_entities/BE0005070,P20036,"HLA class II histocompatibility antigen, DP alpha 1 chain",3113,HLA-DPA1,9606,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
83,1457946,107649,Toxin and Toxin Target Database (T3DB),Beryllium(2+),T3D0042,Beryllium,http://www.t3db.ca/toxins/T3D0042,BE0005069,"HLA class II histocompatibility antigen, DP beta 1 chain",http://www.t3db.ca/biodb/bio_entities/BE0005069,P04440,"HLA class II histocompatibility antigen, DP beta 1 chain",3115,HLA-DPB1,9606,Homo sapiens (human),"Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. this MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. the resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. (L25, A37)",,,PMID:19191908,https://www.ncbi.nlm.nih.gov/pubmed/19191908,19191908,,
84,1457947,107706,ChEMBL,Sivelestat,CHEMBL76688,SIVELESTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL76688/,CHEMBL248,Leukocyte elastase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL248/,P08246,Neutrophil elastase,1991,ELANE,9606,Homo sapiens (human),Leukocyte elastase inhibitor,,,PMID:33033716,https://www.ncbi.nlm.nih.gov/pubmed/33033716,33033716,,
85,1457948,107744,Comparative Toxicogenomics Database (CTD),Aldophosphamide,C006446,aldophosphamide,https://ctdbase.org/detail.go?type=chem&acc=C006446,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216,ALDH1A1,9606,Homo sapiens (human),[ALDH1A1 protein co-treated with NAD] results in increased oxidation of aldophosphamide,,,PMID:10856427,https://www.ncbi.nlm.nih.gov/pubmed/10856427,10856427,,
86,1457949,107744,Comparative Toxicogenomics Database (CTD),Aldophosphamide,C006446,aldophosphamide,https://ctdbase.org/detail.go?type=chem&acc=C006446,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216,ALDH1A1,9606,Homo sapiens (human),ALDH1A1 results in increased oxidation of aldophosphamide,,,PMID:8662658,https://www.ncbi.nlm.nih.gov/pubmed/8662658,8662658,,
87,1457950,107744,Comparative Toxicogenomics Database (CTD),Aldophosphamide,C006446,aldophosphamide,https://ctdbase.org/detail.go?type=chem&acc=C006446,218,ALDH3A1,https://ctdbase.org/detail.go?type=gene&acc=218,,,218,ALDH3A1,9606,Homo sapiens (human),[ALDH3A1 protein co-treated with NADP] results in increased oxidation of aldophosphamide|[aldh3a1 protein co-treated with NAD] results in increased oxidation of aldophosphamide,,,PMID:10856427,https://www.ncbi.nlm.nih.gov/pubmed/10856427,10856427,,
88,1459363,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112,Cyp3a11,10090,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A11 mRNA,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
89,1459364,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,13113,CYP3A13,https://ctdbase.org/detail.go?type=gene&acc=13113,,,13113,Cyp3a13,10090,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
90,1459365,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719,DHFR,9606,Homo sapiens (human),Epicatechin gallate binds to and results in decreased activity of DHFR protein,,,PMID:20054477,https://www.ncbi.nlm.nih.gov/pubmed/20054477,20054477,,
91,1459366,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,1759,DNM1,https://ctdbase.org/detail.go?type=gene&acc=1759,,,1759,DNM1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
92,1459367,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059,DNM1L,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1L protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
93,1459368,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995,ELAVL3,9606,Homo sapiens (human),Epicatechin gallate results in decreased activity of ELAVL3 protein,,,PMID:19192392,https://www.ncbi.nlm.nih.gov/pubmed/19192392,19192392,,
94,1457470,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641,DCX,9606,Homo sapiens (human),Deguelin results in decreased expression of DCX mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
95,1457471,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644,DDC,9606,Homo sapiens (human),Deguelin results in decreased expression of DDC mRNA,,,PMID:33512557|PMID:34642769,https://www.ncbi.nlm.nih.gov/pubmed/33512557|https://www.ncbi.nlm.nih.gov/pubmed/34642769,33512557|34642769,,
96,1457472,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),Deguelin results in increased expression of DDIT3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
97,1457473,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,22898,DENND3,https://ctdbase.org/detail.go?type=gene&acc=22898,,,22898,DENND3,9606,Homo sapiens (human),Deguelin results in decreased expression of DENND3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
98,1457474,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,55789,DEPDC1B,https://ctdbase.org/detail.go?type=gene&acc=55789,,,55789,DEPDC1B,9606,Homo sapiens (human),Deguelin results in increased expression of DEPDC1B mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
99,1457475,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1677,DFFB,https://ctdbase.org/detail.go?type=gene&acc=1677,,,1677,DFFB,9606,Homo sapiens (human),Deguelin results in decreased expression of DFFB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
100,1457476,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,79947,DHDDS,https://ctdbase.org/detail.go?type=gene&acc=79947,,,79947,DHDDS,9606,Homo sapiens (human),Deguelin results in decreased expression of DHDDS mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
101,1457477,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,51635,DHRS7,https://ctdbase.org/detail.go?type=gene&acc=51635,,,51635,DHRS7,9606,Homo sapiens (human),Deguelin results in increased expression of DHRS7 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
102,1459801,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709,HERPUD1,9606,Homo sapiens (human),Deguelin results in increased expression of HERPUD1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
103,1459802,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280,HES1,9606,Homo sapiens (human),Deguelin results in increased expression of HES1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
104,1459803,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3073,HEXA,https://ctdbase.org/detail.go?type=gene&acc=3073,,,3073,HEXA,9606,Homo sapiens (human),Deguelin results in decreased expression of HEXA mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
105,1459804,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074,HEXB,9606,Homo sapiens (human),Deguelin results in increased expression of HEXB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
106,1459805,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,64399,HHIP,https://ctdbase.org/detail.go?type=gene&acc=64399,,,64399,HHIP,9606,Homo sapiens (human),Deguelin results in increased expression of HHIP mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
107,1459806,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091,HIF1A,9606,Homo sapiens (human),Deguelin results in increased degradation of HIF1A protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in increased degradation of HIF1A protein]|deguelin inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein],,,PMID:17764071,https://www.ncbi.nlm.nih.gov/pubmed/17764071,17764071,,
108,1459807,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091,HIF1A,9606,Homo sapiens (human),Deguelin inhibits the reaction [oxygen deficiency results in increased expression of HIF1A protein],,,PMID:17764071|PMID:18575727|PMID:19139008|PMID:22745725|PMID:27899277,https://www.ncbi.nlm.nih.gov/pubmed/17764071|https://www.ncbi.nlm.nih.gov/pubmed/18575727|https://www.ncbi.nlm.nih.gov/pubmed/19139008|https://www.ncbi.nlm.nih.gov/pubmed/22745725|https://www.ncbi.nlm.nih.gov/pubmed/27899277,17764071|18575727|19139008|22745725|27899277,,
109,1459808,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091,HIF1A,9606,Homo sapiens (human),Deguelin metabolite inhibits the reaction [oxygen deficiency results in increased expression of HIF1A protein],,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,
110,1459809,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091,HMGA2,9606,Homo sapiens (human),Deguelin results in increased expression of HMGA2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
111,1459810,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161,HMMR,9606,Homo sapiens (human),Deguelin results in increased expression of HMMR mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
112,1459958,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,56344,CABP5,https://ctdbase.org/detail.go?type=gene&acc=56344,,,56344,CABP5,9606,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CABP5 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
113,1459959,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,27101,CACYBP,https://ctdbase.org/detail.go?type=gene&acc=27101,,,27101,CACYBP,9606,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
114,1459960,107971,Comparative Toxicogenomics Database (CTD),Daidzin,C013908,daidzin,https://ctdbase.org/detail.go?type=chem&acc=C013908,9994,CASP8AP2,https://ctdbase.org/detail.go?type=gene&acc=9994,,,9994,CASP8AP2,9606,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
115,1446150,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294,FBXW7,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mrna] which results in increased expression of FBXW7 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
116,1458238,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3598,IL13RA2,https://ctdbase.org/detail.go?type=gene&acc=3598,,,3598,IL13RA2,9606,Homo sapiens (human),SB 203580 results in decreased expression of IL13RA2 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
117,1458239,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605,IL17A,9606,Homo sapiens (human),SB 203580 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein]|sb 203580 inhibits the reaction [IL17A protein promotes the reaction [TNF protein results in increased expression of IL6 mrna]]|sb 203580 inhibits the reaction [IL17A protein results in increased expression of IL6 protein]|sb 203580 inhibits the reaction [IL17A protein results in increased expression of CXCL8 protein],,,PMID:12016129,https://www.ncbi.nlm.nih.gov/pubmed/12016129,12016129,,
118,1459681,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [IL17A protein promotes the reaction [TNF protein results in increased expression of IL6 mrna]]|sb 203580 inhibits the reaction [IL17A protein results in increased expression of IL6 protein],,,PMID:12016129,https://www.ncbi.nlm.nih.gov/pubmed/12016129,12016129,,
119,1459682,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [IL1A protein results in increased secretion of IL6 protein],,,PMID:16532021,https://www.ncbi.nlm.nih.gov/pubmed/16532021,16532021,,
120,1459683,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein],,,PMID:17388968,https://www.ncbi.nlm.nih.gov/pubmed/17388968,17388968,,
121,1459684,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [IL1B protein results in increased expression of IL6 protein],,,PMID:22727857,https://www.ncbi.nlm.nih.gov/pubmed/22727857,22727857,,
122,1459685,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna],,,PMID:26862037,https://www.ncbi.nlm.nih.gov/pubmed/26862037,26862037,,
123,1459686,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lipopolysaccharides results in increased expression of IL6 protein],,,PMID:20307528|PMID:26862037,https://www.ncbi.nlm.nih.gov/pubmed/20307528|https://www.ncbi.nlm.nih.gov/pubmed/26862037,20307528|26862037,,
124,1459687,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein]|sb 203580 inhibits the reaction [poly I-C results in increased secretion of IL6 protein]|sb 203580 inhibits the reaction [zymosan results in increased secretion of IL6 protein],,,PMID:17698565,https://www.ncbi.nlm.nih.gov/pubmed/17698565,17698565,,
125,1459688,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [melamine results in increased expression of IL6 mrna],,,PMID:22915474,https://www.ncbi.nlm.nih.gov/pubmed/22915474,22915474,,
126,1460261,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein],,,PMID:1970628,https://www.ncbi.nlm.nih.gov/pubmed/1970628,1970628,,
127,1460262,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [tobacco smoke pollution promotes the reaction [particulate matter results in increased expression of IL6 mrna]]|sb 203580 inhibits the reaction [particulate matter promotes the reaction [tobacco smoke pollution results in increased expression of IL6 mrna]]|sb 203580 inhibits the reaction [tobacco smoke pollution results in increased expression of IL6 mrna],,,PMID:22178768,https://www.ncbi.nlm.nih.gov/pubmed/22178768,22178768,,
128,1460263,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [particulate matter results in increased expression of IL6 mrna],,,PMID:19371610,https://www.ncbi.nlm.nih.gov/pubmed/19371610,19371610,,
129,1460264,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mrna],,,PMID:30993381,https://www.ncbi.nlm.nih.gov/pubmed/30993381,30993381,,
130,1460265,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [adenosine triphosphate promotes the reaction [[oleic acid co-treated with palmitic acid] results in increased secretion of IL6 protein]]|sb 203580 inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[oleic acid co-treated with palmitic acid] results in increased secretion of IL6 protein]],,,PMID:25348860,https://www.ncbi.nlm.nih.gov/pubmed/25348860,25348860,,
131,1460266,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein],,,PMID:23624824,https://www.ncbi.nlm.nih.gov/pubmed/23624824,23624824,,
132,1460267,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [diphenylarsinic acid results in increased secretion of IL6 protein],,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
133,1460268,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [lead acetate results in increased expression of IL6 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
134,1457105,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,389558,FAM180A,https://ctdbase.org/detail.go?type=gene&acc=389558,,,389558,FAM180A,9606,Homo sapiens (human),NSC668394 results in increased expression of FAM180A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
135,1457106,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,132720,FAM241A,https://ctdbase.org/detail.go?type=gene&acc=132720,,,132720,FAM241A,9606,Homo sapiens (human),NSC668394 results in increased expression of FAM241A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
136,1457107,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,219738,FAM241B,https://ctdbase.org/detail.go?type=gene&acc=219738,,,219738,FAM241B,9606,Homo sapiens (human),NSC668394 results in increased expression of FAM241B mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
137,1457277,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730,GCLM,9606,Homo sapiens (human),NSC668394 results in increased expression of GCLM mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
138,1457278,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,9245,GCNT3,https://ctdbase.org/detail.go?type=gene&acc=9245,,,9245,GCNT3,9606,Homo sapiens (human),NSC668394 results in increased expression of GCNT3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
139,1457279,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,9518,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,9606,Homo sapiens (human),NSC668394 results in increased expression of GDF15 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
140,1457280,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,2706,GJB2,https://ctdbase.org/detail.go?type=gene&acc=2706,,,2706,GJB2,9606,Homo sapiens (human),NSC668394 results in increased expression of GJB2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
141,1460130,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130,TNFAIP6,9606,Homo sapiens (human),NSC668394 results in increased expression of TNFAIP6 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
142,1460131,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,126282,TNFAIP8L1,https://ctdbase.org/detail.go?type=gene&acc=126282,,,126282,TNFAIP8L1,9606,Homo sapiens (human),NSC668394 results in decreased expression of TNFAIP8L1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
143,1460132,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,8797,TNFRSF10A,https://ctdbase.org/detail.go?type=gene&acc=8797,,,8797,TNFRSF10A,9606,Homo sapiens (human),NSC668394 results in increased expression of TNFRSF10A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
144,1460133,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982,TNFRSF11B,9606,Homo sapiens (human),NSC668394 results in decreased expression of TNFRSF11B mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
145,1460134,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,8744,TNFSF9,https://ctdbase.org/detail.go?type=gene&acc=8744,,,8744,TNFSF9,9606,Homo sapiens (human),NSC668394 results in increased expression of TNFSF9 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
146,1460135,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,10221,TRIB1,https://ctdbase.org/detail.go?type=gene&acc=10221,,,10221,TRIB1,9606,Homo sapiens (human),NSC668394 results in increased expression of TRIB1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
147,1460136,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761,TRIB3,9606,Homo sapiens (human),EZR protein affects the reaction [NSC668394 results in increased expression of TRIB3 mrna]|nsc668394 results in increased expression of TRIB3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
148,1460137,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,147166,TRIM16L,https://ctdbase.org/detail.go?type=gene&acc=147166,,,147166,TRIM16L,9606,Homo sapiens (human),NSC668394 results in increased expression of TRIM16L mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
149,1457780,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,35115,CYP310A1,https://ctdbase.org/detail.go?type=gene&acc=35115,,,35115,Cyp310a1,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of CYP310A1 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
150,1457781,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178697,CYP-32B1,https://ctdbase.org/detail.go?type=gene&acc=178697,,,178697,cyp-32B1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CYP-32B1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
151,1457782,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185591,CYP-33C6,https://ctdbase.org/detail.go?type=gene&acc=185591,,,185591,cyp-33C6,6239,Caenorhabditis elegans,CYP-33C6 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
152,1457783,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,185589,CYP-33C7,https://ctdbase.org/detail.go?type=gene&acc=185589,,,185589,cyp-33C7,6239,Caenorhabditis elegans,CYP-33C7 protein results in increased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of CYP-33C7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
153,1457784,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,187705,CYP-33C8,https://ctdbase.org/detail.go?type=gene&acc=187705,,,187705,cyp-33C8,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of CYP-33C8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
154,1457785,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181852,CYP-34A10,https://ctdbase.org/detail.go?type=gene&acc=181852,,,181852,cyp-34A10,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of CYP-34A10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
155,1457786,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181849,CYP-34A7,https://ctdbase.org/detail.go?type=gene&acc=181849,,,181849,cyp-34A7,6239,Caenorhabditis elegans,CYP-34A7 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
156,1457787,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,182177,CYP-35A2,https://ctdbase.org/detail.go?type=gene&acc=182177,,,182177,cyp-35A2,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CYP-35A2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
157,1457788,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178802,CYP-35A5,https://ctdbase.org/detail.go?type=gene&acc=178802,,,178802,cyp-35A5,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CYP-35A5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
158,1457789,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183193,CYP-36A1,https://ctdbase.org/detail.go?type=gene&acc=183193,,,183193,cyp-36A1,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of CYP-36A1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
159,1459204,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186157,F53C3.1,https://ctdbase.org/detail.go?type=gene&acc=186157,,,186157,F53C3.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F53C3.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
160,1459205,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173731,F53C3.6,https://ctdbase.org/detail.go?type=gene&acc=173731,,,173731,F53C3.6,6239,Caenorhabditis elegans,F53C3.6 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
161,1459678,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186285,F55C5.2,https://ctdbase.org/detail.go?type=gene&acc=186285,,,186285,F55C5.2,6239,Caenorhabditis elegans,F55C5.2 protein results in decreased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of F55C5.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
162,1459679,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186286,F55C5.6,https://ctdbase.org/detail.go?type=gene&acc=186286,,,186286,F55C5.6,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F55C5.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
163,1459680,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186294,F55C9.6,https://ctdbase.org/detail.go?type=gene&acc=186294,,,186294,F55C9.6,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F55C9.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
164,1460744,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,353438,F59B1.10,https://ctdbase.org/detail.go?type=gene&acc=353438,,,353438,F59B1.10,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F59B1.10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
165,1460745,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178784,F59B1.8,https://ctdbase.org/detail.go?type=gene&acc=178784,,,178784,F59B1.8,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F59B1.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
166,1460746,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186593,F59B2.8,https://ctdbase.org/detail.go?type=gene&acc=186593,,,186593,F59B2.8,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F59B2.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
167,1460747,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186594,F59B2.9,https://ctdbase.org/detail.go?type=gene&acc=186594,,,186594,F59B2.9,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F59B2.9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
168,1460748,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186642,F59H6.3,https://ctdbase.org/detail.go?type=gene&acc=186642,,,186642,F59H6.3,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F59H6.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
169,1460749,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157,F8,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of F8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
170,1460750,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2158,F9,https://ctdbase.org/detail.go?type=gene&acc=2158,,,2158,F9,10116,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in decreased expression of F9 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
171,1460751,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100380490,FA55C,https://ctdbase.org/detail.go?type=gene&acc=100380490,,,100380490,,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of FA55C mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
172,1460752,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,45577,FAA,https://ctdbase.org/detail.go?type=gene&acc=45577,,,45577,Faa,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of FAA mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
173,1460753,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2166,FAAH,https://ctdbase.org/detail.go?type=gene&acc=2166,,,2166,FAAH,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of FAAH mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
174,1458730,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,50810,HDGFL3,https://ctdbase.org/detail.go?type=gene&acc=50810,,,50810,HDGFL3,9606,Homo sapiens (human),Lithium chloride results in decreased expression of HDGFL3 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
175,1458731,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,117464,HE,https://ctdbase.org/detail.go?type=gene&acc=117464,,,117464,He,7668,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in increased expression of HE mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
176,1458732,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280,HES1,7668,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in decreased expression of HES1 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
177,1458733,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,84667,HES7,https://ctdbase.org/detail.go?type=gene&acc=84667,,,84667,HES7,10090,Mus musculus (house mouse),Lithium chloride results in increased expression of HES7 mRNA,,,PMID:23326414,https://www.ncbi.nlm.nih.gov/pubmed/23326414,23326414,,
178,1458734,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146,HMGB1,10116,Rattus norvegicus (Norway rat),[lithium chloride co-treated with pilocarpine] affects the reaction [dexamethasone results in increased expression of HMGB1 mrna]|[lithium chloride co-treated with pilocarpine] affects the reaction [dexamethasone results in increased expression of HMGB1 protein],,,PMID:32494933,https://www.ncbi.nlm.nih.gov/pubmed/32494933,32494933,,
179,1458735,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),Lithium chloride promotes the reaction [sesquiterpenes analog results in increased expression of HMOX1 protein],,,PMID:30672058,https://www.ncbi.nlm.nih.gov/pubmed/30672058,30672058,,
180,1458736,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),[lithium chloride results in increased abundance of lithium] which results in increased expression of HMOX1 mRNA,,,PMID:26074776,https://www.ncbi.nlm.nih.gov/pubmed/26074776,26074776,,
181,1458737,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),Lithium chloride results in increased expression of HMOX1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
182,1458384,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128,MAOA,9606,Homo sapiens (human),MAOA protein results in increased metabolism of norepinephrine,,,PMID:10647887,https://www.ncbi.nlm.nih.gov/pubmed/10647887,10647887,,
183,1458385,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128,MAOA,10090,Mus musculus (house mouse),MAOA mutant form results in increased abundance of norepinephrine,,,PMID:11834493,https://www.ncbi.nlm.nih.gov/pubmed/11834493,11834493,,
184,1458386,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128,MAOA,9606,Homo sapiens (human),MAOA protein results in decreased amination of norepinephrine,,,PMID:22023459,https://www.ncbi.nlm.nih.gov/pubmed/22023459,22023459,,
185,1459369,441199,Comparative Toxicogenomics Database (CTD),Cefoxitin,D002440,Cefoxitin,https://ctdbase.org/detail.go?type=chem&acc=D002440,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,10090,Mus musculus (house mouse),[gentamicins co-treated with vancomycin co-treated with cefoxitin co-treated with metronidazole] inhibits the reaction [fluorides results in increased expression of IFNG mrna],,,PMID:37269894,https://www.ncbi.nlm.nih.gov/pubmed/37269894,37269894,,
186,1459370,441199,Comparative Toxicogenomics Database (CTD),Cefoxitin,D002440,Cefoxitin,https://ctdbase.org/detail.go?type=chem&acc=D002440,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551,IKBKB,10090,Mus musculus (house mouse),[gentamicins co-treated with vancomycin co-treated with cefoxitin co-treated with metronidazole] inhibits the reaction [fluorides results in increased expression of IKBKB mrna],,,PMID:37269894,https://www.ncbi.nlm.nih.gov/pubmed/37269894,37269894,,
187,1459371,441199,Comparative Toxicogenomics Database (CTD),Cefoxitin,D002440,Cefoxitin,https://ctdbase.org/detail.go?type=chem&acc=D002440,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586,IL10,10090,Mus musculus (house mouse),[gentamicins co-treated with vancomycin co-treated with cefoxitin co-treated with metronidazole] inhibits the reaction [fluorides results in increased expression of IL10 mrna],,,PMID:37269894,https://www.ncbi.nlm.nih.gov/pubmed/37269894,37269894,,
188,1459372,441199,Comparative Toxicogenomics Database (CTD),Cefoxitin,D002440,Cefoxitin,https://ctdbase.org/detail.go?type=chem&acc=D002440,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10090,Mus musculus (house mouse),[gentamicins co-treated with vancomycin co-treated with cefoxitin co-treated with metronidazole] inhibits the reaction [fluorides results in increased expression of IL1B mrna],,,PMID:37269894,https://www.ncbi.nlm.nih.gov/pubmed/37269894,37269894,,
189,1459373,441199,Comparative Toxicogenomics Database (CTD),Cefoxitin,D002440,Cefoxitin,https://ctdbase.org/detail.go?type=chem&acc=D002440,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),[gentamicins co-treated with vancomycin co-treated with cefoxitin co-treated with metronidazole] inhibits the reaction [fluorides results in increased expression of IL6 mrna],,,PMID:37269894,https://www.ncbi.nlm.nih.gov/pubmed/37269894,37269894,,
190,1460429,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348,APOE,10090,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of MIR21A mrna]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of IL6 protein]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in decreased abundance of glutathione]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of TNF protein]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of IFNG protein]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in decreased expression of MIR20A mrna]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased abundance of cholesterol]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased abundance of triglycerides]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of IL2 protein]|notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased expression of MIR126A mrna],,,PMID:24933211,https://www.ncbi.nlm.nih.gov/pubmed/24933211,24933211,,
191,1460430,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351,APP,10090,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in increased expression of APP protein modified form],,,PMID:25714973,https://www.ncbi.nlm.nih.gov/pubmed/25714973,25714973|25714973,,
192,1460431,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351,APP,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK1 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased cleavage of CASP3 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK3 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK8 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK9 protein]|notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased expression of BAX protein],,,PMID:24975829,https://www.ncbi.nlm.nih.gov/pubmed/24975829,24975829,,
193,1460593,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased expression of BAX protein],,,PMID:24975829,https://www.ncbi.nlm.nih.gov/pubmed/24975829,24975829,,
194,1460594,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [[oxygen co-treated with [oxygen deficiency co-treated with glucose deficiency]] results in increased expression of BAX protein],,,PMID:25305180,https://www.ncbi.nlm.nih.gov/pubmed/25305180,25305180,,
195,1460595,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10090,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [excitatory amino acid agonists results in decreased expression of BCL2 protein],,,PMID:19224577,https://www.ncbi.nlm.nih.gov/pubmed/19224577,19224577,,
196,1460596,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10090,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [lipopolysaccharides results in decreased expression of BCL2 protein],,,PMID:23170834,https://www.ncbi.nlm.nih.gov/pubmed/23170834,23170834,,
197,1460597,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100,ESR2,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 results in increased expression of ESR2,,,PMID:24720662,https://www.ncbi.nlm.nih.gov/pubmed/24720662,24720662,,
198,1460598,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10116,Rattus norvegicus (Norway rat),"Notoginsenoside R1 inhibits the reaction [[oxygen co-treated with [oxygen deficiency co-treated with glucose deficiency]] results in decreased expression of BCL2 protein]|15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[oxygen co-treated with [oxygen deficiency co-treated with glucose deficiency]] results in decreased expression of BCL2 protein]]",,,PMID:25305180,https://www.ncbi.nlm.nih.gov/pubmed/25305180,25305180,,
199,1460599,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein],,,PMID:24975829,https://www.ncbi.nlm.nih.gov/pubmed/24975829,24975829,,
200,1460600,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 results in increased expression of BCL2,,,PMID:20023602,https://www.ncbi.nlm.nih.gov/pubmed/20023602,20023602,,
201,1460601,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632,BGLAP,9606,Homo sapiens (human),Notoginsenoside R1 results in increased expression of BGLAP mrna|fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of BGLAP mrna],,,PMID:26362186,https://www.ncbi.nlm.nih.gov/pubmed/26362186,26362186,,
202,1457478,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578,PRKCA,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKCA mRNA,,,PMID:16507463,https://www.ncbi.nlm.nih.gov/pubmed/16507463,16507463,,
203,1457479,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578,PRKCA,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRKCA mRNA,,,PMID:12016162,https://www.ncbi.nlm.nih.gov/pubmed/12016162,12016162,,
204,1457480,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578,PRKCA,10116,Rattus norvegicus (Norway rat),Sodium arsenite promotes the reaction [AGO2 protein binds to PRKCA protein],,,PMID:30404558,https://www.ncbi.nlm.nih.gov/pubmed/30404558,30404558,,
205,1458727,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544,PROCR,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PROCR mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
206,1458728,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625,PRODH,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRODH mRNA,,,PMID:20339138,https://www.ncbi.nlm.nih.gov/pubmed/20339138,20339138,,
207,1458729,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,58510,PRODH2,https://ctdbase.org/detail.go?type=gene&acc=58510,,,58510,PRODH2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRODH2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
208,1458897,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,128674,PROKR2,https://ctdbase.org/detail.go?type=gene&acc=128674,,,128674,PROKR2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PROKR2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
209,1458898,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,17830,PROL1,https://ctdbase.org/detail.go?type=gene&acc=17830,,,17830,Prol1,9606,Homo sapiens (human),Sodium arsenite affects the methylation of PROL1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
210,1458899,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842,PROM1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PROM1 mRNA,,,PMID:29301061|PMID:31120745,https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/31120745,29301061|31120745,,
211,1458900,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842,PROM1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of PROM1 protein|sodium arsenite results in increased expression of PROM1 mRNA,,,PMID:23137061,https://www.ncbi.nlm.nih.gov/pubmed/23137061,23137061,,
212,1458901,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,322857,PROM1A,https://ctdbase.org/detail.go?type=gene&acc=322857,,,322857,prom1a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PROM1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
213,1458902,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696,PROM2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PROM2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
214,1458903,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696,PROM2,9606,Homo sapiens (human),Sodium arsenite results in decreased methylation of PROM2 gene|sodium arsenite results in increased expression of PROM2 mRNA,,,PMID:24570342,https://www.ncbi.nlm.nih.gov/pubmed/24570342,24570342,,
215,1458904,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696,PROM2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PROM2 mRNA,,,PMID:36209798|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/36209798|https://www.ncbi.nlm.nih.gov/pubmed/37682722,36209798|37682722,,
216,1459054,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5629,PROX1,https://ctdbase.org/detail.go?type=gene&acc=5629,,,5629,PROX1,8078,Fundulus heteroclitus (mummichog),Sodium arsenite affects the expression of PROX1 mRNA,,,PMID:22058191,https://www.ncbi.nlm.nih.gov/pubmed/22058191,22058191,,
217,1459055,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5629,PROX1,https://ctdbase.org/detail.go?type=gene&acc=5629,,,5629,PROX1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PROX1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
218,1459056,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5629,PROX1,https://ctdbase.org/detail.go?type=gene&acc=5629,,,5629,PROX1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PROX1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
219,1459057,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,30679,PROX1A,https://ctdbase.org/detail.go?type=gene&acc=30679,,,30679,prox1a,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PROX1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
220,1459058,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,558106,PROZB,https://ctdbase.org/detail.go?type=gene&acc=558106,,,558106,prozb,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PROZB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
221,1459059,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,177840,PRP-18,https://ctdbase.org/detail.go?type=gene&acc=177840,,,177840,prp-18,6239,Caenorhabditis elegans,PRP-18 mRNA promotes the reaction [sodium arsenite results in increased expression of GCS-1 protein],,,PMID:25204677,https://www.ncbi.nlm.nih.gov/pubmed/25204677,25204677,,
222,1459060,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8559,PRPF18,https://ctdbase.org/detail.go?type=gene&acc=8559,,,8559,PRPF18,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRPF18 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
223,1459061,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27339,PRPF19,https://ctdbase.org/detail.go?type=gene&acc=27339,,,27339,PRPF19,9606,Homo sapiens (human),Sodium arsenite affects the expression of PRPF19 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
224,1459062,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26121,PRPF31,https://ctdbase.org/detail.go?type=gene&acc=26121,,,26121,PRPF31,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRPF31 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
225,1459063,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55015,PRPF39,https://ctdbase.org/detail.go?type=gene&acc=55015,,,55015,PRPF39,9606,Homo sapiens (human),Sodium arsenite affects the expression of PRPF39 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
226,1459195,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4168,MCF2,https://ctdbase.org/detail.go?type=gene&acc=4168,,,4168,MCF2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MCF2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
227,1459196,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4168,MCF2,https://ctdbase.org/detail.go?type=gene&acc=4168,,,4168,MCF2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MCF2 mRNA,,,PMID:12016162,https://www.ncbi.nlm.nih.gov/pubmed/12016162,12016162,,
228,1459197,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263,MCF2L,9606,Homo sapiens (human),Sodium arsenite affects the methylation of MCF2L gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
229,1459198,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263,MCF2L,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MCF2L mrna|sodium arsenite results in decreased methylation of MCF2L gene,,,PMID:24570342,https://www.ncbi.nlm.nih.gov/pubmed/24570342,24570342,,
230,1459199,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23101,MCF2L2,https://ctdbase.org/detail.go?type=gene&acc=23101,,,23101,MCF2L2,9541,Macaca fascicularis (crab-eating macaque),Sodium arsenite results in decreased expression of MCF2L2 protein,,,PMID:24866292,https://www.ncbi.nlm.nih.gov/pubmed/24866292,24866292,,
231,1459200,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100289410,MCF2L-AS1,https://ctdbase.org/detail.go?type=gene&acc=100289410,,,100289410,MCF2L-AS1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MCF2L-AS1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
232,1459201,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2847,MCHR1,https://ctdbase.org/detail.go?type=gene&acc=2847,,,2847,MCHR1,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of MCHR1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
233,1459202,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,157777,MCMDC2,https://ctdbase.org/detail.go?type=gene&acc=157777,,,157777,MCMDC2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased methylation of MCMDC2 gene,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
234,1459203,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,255231,MCOLN2,https://ctdbase.org/detail.go?type=gene&acc=255231,,,255231,MCOLN2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MCOLN2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
235,1459811,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79056,PRRG4,https://ctdbase.org/detail.go?type=gene&acc=79056,,,79056,PRRG4,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRRG4 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
236,1460127,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8811,GALR2,https://ctdbase.org/detail.go?type=gene&acc=8811,,,8811,GALR2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of GALR2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
237,1460128,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592,GALT,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of GALT mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
238,1460129,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593,GAMT,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GAMT mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
239,1460602,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,130752,MDH1B,https://ctdbase.org/detail.go?type=gene&acc=130752,,,130752,MDH1B,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MDH1B mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
240,1607473,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),MALAT1 mRNA promotes the reaction [sodium arsenite results in increased expression of VEGFA mrna],,,PMID:26735578,https://www.ncbi.nlm.nih.gov/pubmed/26735578,26735578,,
241,1607474,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),"[oligodeoxyribonucleotides, antisense results in decreased expression of EPAS1 protein] inhibits the reaction [sodium arsenite results in increased expression of VEGFA protein]",,,PMID:30090327,https://www.ncbi.nlm.nih.gov/pubmed/30090327,30090327,,
242,1607475,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),PRKAA1 protein affects the reaction [sodium arsenite results in increased expression of VEGFA mrna]|prkaa1 protein affects the reaction [sodium arsenite results in increased secretion of VEGFA protein],,,PMID:16678800,https://www.ncbi.nlm.nih.gov/pubmed/16678800,16678800,,
243,1458099,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10929,SRSF8,https://ctdbase.org/detail.go?type=gene&acc=10929,,,10929,SRSF8,9606,Homo sapiens (human),Trichostatin A affects the expression of SRSF8 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
244,1458100,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51188,SS18L2,https://ctdbase.org/detail.go?type=gene&acc=51188,,,51188,SS18L2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SS18L2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
245,1458101,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51188,SS18L2,https://ctdbase.org/detail.go?type=gene&acc=51188,,,51188,SS18L2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of SS18L2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
246,1458102,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23635,SSBP2,https://ctdbase.org/detail.go?type=gene&acc=23635,,,23635,SSBP2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SSBP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
247,1458103,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23635,SSBP2,https://ctdbase.org/detail.go?type=gene&acc=23635,,,23635,SSBP2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of SSBP2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
248,1458104,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082,SSPN,9606,Homo sapiens (human),Trichostatin A results in decreased expression of SSPN mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
249,1458105,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745,SSR1,9606,Homo sapiens (human),Trichostatin A results in increased expression of SSR1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
250,1458106,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6750,SST,https://ctdbase.org/detail.go?type=gene&acc=6750,,,6750,SST,9606,Homo sapiens (human),Trichostatin A results in increased expression of SST mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
251,1459053,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777,STAT5B,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT5B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
252,1459503,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614,STC2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STC2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
253,1459504,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614,STC2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of STC2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
254,1459505,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872,STEAP1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
255,1459506,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872,STEAP1,9606,Homo sapiens (human),Trichostatin A results in increased expression of STEAP1 mRNA,,,PMID:24935251|PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,24935251|26272509|27188386,,
256,1459507,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,256227,STEAP1B,https://ctdbase.org/detail.go?type=gene&acc=256227,,,256227,STEAP1B,9606,Homo sapiens (human),Trichostatin A results in increased expression of STEAP1B mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
257,1459508,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,261729,STEAP2,https://ctdbase.org/detail.go?type=gene&acc=261729,,,261729,STEAP2,9606,Homo sapiens (human),Trichostatin A results in increased expression of STEAP2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
258,1459509,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55240,STEAP3,https://ctdbase.org/detail.go?type=gene&acc=55240,,,55240,STEAP3,9606,Homo sapiens (human),Trichostatin A results in increased expression of STEAP3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
259,1459510,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,375346,STIMATE,https://ctdbase.org/detail.go?type=gene&acc=375346,,,375346,STIMATE,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of STIMATE mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
260,2056390,51049968,DrugBank,Rimegepant,DB12457,Rimegepant,https://www.drugbank.ca/drugs/DB12457,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576,CYP3A4,9606,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
261,2056391,51049968,DrugBank,Rimegepant,DB12457,Rimegepant,https://www.drugbank.ca/drugs/DB12457,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559,CYP2C9,9606,Homo sapiens (human),Substrate,,,,,,,
